Breaking News: Embargoed Feed - hidden

Filters close
22-May-2020 3:05 PM EDT
Biomarkers May Help Us Understand Recovery Time After Concussion
American Academy of Neurology (AAN)

A blood test may help researchers understand which people may take years to recover from concussion, according to a study published in the May 27, 2020 online issue of Neurology®, the medical journal of the American Academy of Neurology. The study looked at a biomarker called neurofilament light chain, a nerve protein that can be detected in the blood when nerve cells are injured or die.

Newswise: iX0OVC4Z6dvBBJS7iKIQmpro1OPwuVvs_93Jqp5Y8Q_YNZi7vi4rIUUt96eE4luAxERxuoQ5YOcI8yDb51NuyGAuHMf90l6wxvu4NbmvVOxHKx3P717rJcalzzFeOrHU07epzpEsRR96lKxhZIBWQrJCwdosVBAm1ivQtBOORbkomBrWYRvqHQJqKL6bGiVMYIQPn-7Q_-yRyCJiSP4=s0-
21-May-2020 10:50 AM EDT
In stressed ecosystems Jurassic dinosaurs turned to scavenging, maybe even cannibalism
PLOS

Among dinosaurs of ancient Colorado, scavenging and possibly cannibalism were responses to a resource-scarce environment, according to a study published May 27, 2020 in the open-access journal PLOS ONE by Stephanie Drumheller of the University of Tennessee, Knoxville, and colleagues.

22-May-2020 11:45 AM EDT
A few months of vaping puts healthy people on the brink of oral disease
Ohio State University

The collection of oral bacteria in daily e-cigarette users’ mouths is teeming with potent infection-causing organisms that put vapers at substantial risk for ailments ranging from gum disease to cancer, researchers found.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Jun-2020 12:05 AM EDT Released to reporters: 27-May-2020 1:15 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Jun-2020 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 29-May-2020 11:00 AM EDT Released to reporters: 27-May-2020 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-May-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: ‘Nature’s antifreeze’ provides formula for more durable concrete
21-May-2020 8:00 AM EDT
‘Nature’s antifreeze’ provides formula for more durable concrete
University of Colorado Boulder

Secrets to cementing the sustainability of our future infrastructure may come from nature, such as proteins that keep plants and animals from freezing in extremely cold conditions. CU Boulder researchers have discovered that a synthetic molecule based on natural antifreeze proteins minimizes freeze-thaw damage and increases the strength and durability of concrete, improving the longevity of new infrastructure and decreasing carbon emissions over its lifetime.

22-May-2020 12:05 PM EDT
Follow-up Treatments After Opioid Overdose Rare Among Insured Patients
Perelman School of Medicine at the University of Pennsylvania

Of nearly 6,500 commercially insured patients treated in EDs nationwide for an overdose or other opioid-related medical complications, only 16 percent accessed opioid use disorder (OUD) medications or another form of treatment within three months of the ED visit.

Newswise: Treatment shows promise in treating deadly brain cancer
25-May-2020 8:55 AM EDT
Treatment shows promise in treating deadly brain cancer
McMaster University

In this study, researchers investigated if specific targeting of CD133+ glioblastoma with cutting-edge immunotherapy drugs could eradicate the most aggressive subpopulation of cells in the tumour. They also looked at the safety of CD133-targeting therapies on normal, non-cancerous human stem cells including hematopoietic stem cells which create blood cells and progenitor cells which can form one or more kinds of cells.

access_time Embargo lifts in 2 days
Embargo will expire: 29-May-2020 12:05 AM EDT Released to reporters: 27-May-2020 9:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-May-2020 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

22-May-2020 9:30 AM EDT
Winds spread PFAS pollution far from a manufacturing facility
American Chemical Society (ACS)

Concerns about environmental and health risks of some fluorinated carbon compounds have prompted manufacturers to develop substitutes, but these replacements are increasingly coming under fire themselves. Scientists have been studying how widely these chemicals have contaminated the environment.


Showing results

110 of 10

close
3.57442